Literature DB >> 31412276

Human toxocariasis - A look at a neglected disease through an epidemiological 'prism'.

Ali Rostami1, Guangxu Ma2, Tao Wang2, Anson V Koehler2, Andreas Hofmann2, Bill C H Chang2, Calum N Macpherson3, Robin B Gasser4.   

Abstract

Toxocariasis, a disease caused by infection with larvae of Toxocara canis, T. cati and/or congeners, represents clinical syndromes in humans including visceral and ocular larva migrans, neurotoxocariasis and covert/common toxocariasis. It is reported to be one of the most widespread public health and economically important zoonotic parasitic infections that humans share with dogs, wild canids, including foxes, and possibly other mammals. Humans become infected by accidental ingestion of embryonated Toxocara eggs, or larvae from tissues from domestic or wild paratenic hosts. Most infections are asymptomatic, and human disease may go unnoticed, as clinical investigation is often not pursued and/or diagnostic testing not conducted. Sometimes toxocariasis can be associated with complications, such as allergic and/or neurological disorders, possibly including cognitive or developmental delays in children. There is no anti-toxocariasis vaccine, and chemotherapy in humans varies, depending on symptoms and location of larvae, and may include the administration of albendazole or mebendazole, together with anti-inflammatory corticosteroids. Some recent studies indicate that toxocariasis is having an increased, adverse impact on human health in some, particularly underprivileged, tropical and subtropical communities around the world. Although tens of millions of people, especially children, are expected to be exposed to, or infected with Toxocara species, there is limited precise epidemiological data or information on the relationship between seropositivity and disease (toxocariasis) on a global scale. To gain an improved insight into this area, the present article reviews salient clinical aspects of human toxocariasis and the epidemiology of this disease, with particular reference to seroprevalence, and discusses future research and approaches/measures to understand and prevent/control this socioeconomically important, yet neglected zoonosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemiology; Larva migrans; Seroprevalence; Toxocara canis; Toxocara cati; Toxocariasis

Mesh:

Substances:

Year:  2019        PMID: 31412276     DOI: 10.1016/j.meegid.2019.104002

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  15 in total

Review 1.  Neuroimmunology of Common Parasitic Infections in Africa.

Authors:  Richard Idro; Rodney Ogwang; Antonio Barragan; Joseph Valentino Raimondo; Willias Masocha
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

2.  Toxocara canis Infection Alters mRNA Expression Profiles of Peripheral Blood Mononuclear Cells in Beagle Dogs at the Lung Infection Period.

Authors:  Lang Cai; Yang Zou; Yue Xu; Hao-Yu Li; Shi-Chen Xie; Xing-Quan Zhu; Wen-Bin Zheng
Journal:  Animals (Basel)       Date:  2022-06-10       Impact factor: 3.231

3.  Exposure to Toxocara spp. and Ascaris lumbricoides infections and risk of allergic rhinitis in children.

Authors:  Iraj Mohammadzadeh; Sorena Darvish; Seyed Mohammad Riahi; Solmaz Alizadeh Moghaddam; Mohammad Pournasrollah; Mousa Mohammadnia-Afrozi; Ali Rostami
Journal:  Allergy Asthma Clin Immunol       Date:  2020-07-30       Impact factor: 3.406

4.  Human toxocariasis and atopy.

Authors:  Jean-François Magnaval; Judith Fillaux; Sophie Cassaing; Alexis Valentin; Xavier Iriart; Antoine Berry
Journal:  Parasite       Date:  2020-05-13       Impact factor: 3.000

Review 5.  The Presence of Toxocara Eggs on Dog's Fur as Potential Zoonotic Risk in Animal-Assisted Interventions: A Systematic Review.

Authors:  Maria Paola Maurelli; Antonio Santaniello; Alessandro Fioretti; Giuseppe Cringoli; Laura Rinaldi; Lucia Francesca Menna
Journal:  Animals (Basel)       Date:  2019-10-19       Impact factor: 2.752

6.  Seroprevalence estimates for toxocariasis in people worldwide: A systematic review and meta-analysis.

Authors:  Ali Rostami; Seyed Mohammad Riahi; Celia V Holland; Ali Taghipour; Mohsen Khalili-Fomeshi; Yadolah Fakhri; Vahid Fallah Omrani; Peter J Hotez; Robin B Gasser
Journal:  PLoS Negl Trop Dis       Date:  2019-12-19

7.  "Begging the Question"-Does Toxocara Infection/Exposure Associate with Multiple Sclerosis-Risk?

Authors:  Ali Taghipour; Ali Rostami; Sahar Esfandyari; Saeed Aghapour; Alessandra Nicoletti; Robin B Gasser
Journal:  Pathogens       Date:  2020-11-11

8.  Toxocara canis Infection Alters lncRNA and mRNA Expression Profiles of Dog Bone Marrow.

Authors:  Wen-Bin Zheng; Yang Zou; Qing Liu; Min-Hua Hu; Hany M Elsheikha; Xing-Quan Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-30

9.  Toxocara infection: seroprevalence and associated risk factors among primary school children in central China.

Authors:  Shuai Wang; Haoran Li; Zhijun Yao; Pengju Li; Dong Wang; Haizhu Zhang; Qing Xie; Zhenchao Zhang; Xiangrui Li
Journal:  Parasite       Date:  2020-05-05       Impact factor: 3.000

10.  Seroprevalence of Toxocara canis infection and associated risk factors among primary schoolchildren in rural Southern Thailand.

Authors:  Nonthapan Phasuk; Chuchard Punsawad
Journal:  Trop Med Health       Date:  2020-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.